NCT02537002View on ClinicalTrials.gov

Single Dose Study of PF-05230907 in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

PF-05230907

A single intravenous dose of 3 μg/kg

DRUG

PF-05230907

A single intravenous dose of 5 μg/kg

DRUG

Placebo

A single intravenous dose of matched placebo

Trial Locations (1)

06511-5473

Pfizer New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02537002 - Single Dose Study of PF-05230907 in Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter